Touyun Biotech Group Cash Flow Statement

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-88.11	-268.94	-198.07	-72.95
Depreciation & Amortization	29.48	36.59	32.22	21.3
Other Amortization	-	-	0.92	1.41
Loss (Gain) From Sale of Assets	1.03	2.05	2.82	22.91
Asset Writedown & Restructuring Costs	-	78.75	-	-
Loss (Gain) From Sale of Investments	33.56	100.43	150.17	54.05
Stock-Based Compensation	3.64	2.59	6.86	16.18
Provision & Write-off of Bad Debts	3.9	2.48	7.9	0.46
Other Operating Activities	-1.9	10.81	0.11	-67.51
Change in Accounts Receivable	1.58	5.97	15.43	-142.48
Change in Inventory	-9.88	3.22	-2.85	0.98
Change in Accounts Payable	-3.25	-12.27	-25.6	34.87
Change in Other Net Operating Assets	28.92	18.54	-23.98	68.2
Operating Cash Flow	-49.87	2.18	-26.37	-53.81
Capital Expenditures	-3.66	-17.13	-12.93	-163.51
Sale of Property, Plant & Equipment	0.43	1.19	1.15	3.28
Divestitures	-	-	-	152.08
Sale (Purchase) of Real Estate	-	-	-	-87.28
Investment in Securities	-	-55	-5.47	-52.3
Other Investing Activities	-1.42	-	-	-
Investing Cash Flow	-4.66	-70.95	-17.25	-147.74
Short-Term Debt Issued	13.08	7.66	13.9	-
Long-Term Debt Issued	91.85	106.37	315.9	348.64
Total Debt Issued	104.94	114.02	329.81	348.64
Short-Term Debt Repaid	-	-1.14	-3.63	-16.52
Long-Term Debt Repaid	-89.19	-145.1	-230.54	-247.33
Total Debt Repaid	-89.19	-146.24	-234.18	-263.85
Net Debt Issued (Repaid)	15.74	-32.21	95.63	84.79
Issuance of Common Stock	-	-	-	31.27
Other Financing Activities	20	6	7	7.12
Financing Cash Flow	35.74	-26.21	102.63	123.17
Foreign Exchange Rate Adjustments	0.61	1.37	8.89	-3.86
Net Cash Flow	-18.18	-93.61	67.9	-82.24
Free Cash Flow	-53.54	-14.95	-39.3	-217.32
Free Cash Flow Margin	-33.47%	-7.53%	-12.44%	-76.66%
Free Cash Flow Per Share	-0.02	-0.01	-0.01	-0.08
Cash Interest Paid	9.6	7.59	18.76	31.06
Cash Income Tax Paid	-	2.53	1.51	3.3
Levered Free Cash Flow	14.57	7.01	-28.85	-89.05
Unlevered Free Cash Flow	20.88	11.66	-15.31	-78.33
Change in Working Capital	-29.88	34.71	-29.3	-23.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.